DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Virtual Event

2020年11月09日 (月) 午前 10:00 - 2020年11月10日 (火) 午後 3:45

(US Eastern Standard Time)

Fort Washington, PA 19034

Real World Evidence Conference

Session 7: Case Study: COVID R&D Alliance, RWE Informing COVID-19 Drug Development and Closing Remarks

Session Chair(s)

Brian  Bradbury, DrSc, MA

Brian Bradbury, DrSc, MA

Vice President, Center for Observational Research

Amgen, United States

Marni  Hall, PhD, MPH

Marni Hall, PhD, MPH

Vice President and General Manager, Global Regulatory Science and Strategy

IQVIA, United States

This session provides an introduction to the COVID R&D Alliance and how the use of RWE is assisting in the design of platforms trials and providing evidence regarding the natural history of disease for patients diagnosed with COVID-19. Emphasis will be placed on the value of coordinated and collaborative engagement across manufactures and the lessons learned from this effort.

Learning Objective :
  • Describe the COVID R&D Alliance and the collaborative approach that manufacturers are taking to accelerate the testing of repurposed medicines as potential treatment
  • Discuss ongoing R&D Alliance RWE studies designed to better inform on the natural history of disease and the safety of treatments
  • Apply lessons learned from COVID R&D Alliance RWE collaborations to research efforts in the post-COVID environment

Speaker(s)

Anne  Heatherington, PhD

Speaker

Anne Heatherington, PhD

Takeda Pharmaceuticals, United States

Senior Vice President, Head of Data Sciences Institute

Cathy W Critchlow, PhD, MSc

Speaker

Cathy W Critchlow, PhD, MSc

Amgen, Inc, United States

Vice President, R&D Data Strategy

Ying  Bao, DrSc, MD

Speaker

Ying Bao, DrSc, MD

Bristol Myers Squibb, United States

Senior Director, Center for Observational Research and Data Science

Brian  Bradbury, DrSc, MA

Closing Remarks

Brian Bradbury, DrSc, MA

Amgen, United States

Vice President, Center for Observational Research

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。